Forward Citations = 19

Loading Chart...

1 inventor (with patents filed for the assignee):

Andrew Xian Chen (4 out of 36 patents)

4 patents: Sort by Forward Citations

1. 8222268 - Methods for reducing vein irritation (2012-07-17),

2. 8026250 - Compositions for delivering highly water soluble drugs (2011-09-27),

3. 7968122 - Anti-viral pharmaceutical compositions (2011-06-28),

4. 7871632 - Compositions for delivering highly water soluble drugs (2011-01-18),

Adventrx Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of proprietary product candidates for the treatment of cancer and infectious diseases. The company's lead product candidate is Ethyol, a cytoprotective agent used in cancer therapy to reduce the incidence of chemotherapy-induced side effects. Adventrx is dedicated to improving patient outcomes and quality of life through innovative drug development.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#974 in San Diego, CA

#13,675 in California

#59,046 in US

San Diego, CA, United States of America

Adventrx Pharmaceuticals, Inc.

Forward Citations = 19

1 inventor:

Andrew Xian Chen (4 out of 36 patents)

Please report any incorrect information to support@idiyas.com